Lupus · 2013 · 26 citations · 9 references
Life SciencesClinical SciencesImmunologyAutoimmunityImmunotherapyRheumatologyAutoimmune DiseasesAutoimmune Rheumatic DiseasesImmune-mediated Inflammatory DiseasesInflammatory ArthritisPsoriatic ArthritisRheumatoid ArthritisChimeric Monoclonal AntibodiesImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingRheumatic InflammationRheumatoid Arthritis PharmacotherapyRheumatoid Arthritis TherapyTumor Necrosis Factor Inhibitor Therapy
Anti-tumor necrosis factor-alpha (TNF-α) immunotherapy is currently used in the treatment of various inflammatory diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. Infliximab is a chimeric monoclonal antibody that binds to transmembrane-bound and soluble TNF-α. Previously, a discoid lupus erythematosus-like eruption linked to its use was rarely reported in patients with rheumatoid arthritis. We present a case of rheumatoid arthritis which developed such an eruption after treatment with infliximab. The lesions resolved after the discontinuation of infliximab. In the present case, the clinical, serological and immunohistochemical features of our patient are discussed with the literature.
9
Induction of apoptosis in mature T cells by tumour necrosis factor
Lixin Zheng, Galen H. Fisher, Robert E. Miller et al. · Nature · 1995 · 1.1K citations
Anti-TNF-?-induced systemic lupus syndrome
M. Debandt, Olivier Vittecoq, V. Descamps et al. · Clinical Rheumatology · 2003 · 191 citations